Get the Stockscreener App
5.52
1.85%
0.10
After Hours:
5.49
-0.03
-0.54%
Sophia Genetics Sa stock is traded at $5.52, with a volume of 429.17K.
It is up +1.85% in the last 24 hours and up +15.48% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$5.42
Open:
$5.5
24h Volume:
429.17K
Relative Volume:
2.85
Market Cap:
$374.52M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-5.0642
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
+6.98%
1M Performance:
+15.48%
6M Performance:
+60.93%
1Y Performance:
+50.00%
1-Day Range:
$5.4568
$5.70
1-Week Range:
$5.00
$5.70
52-Week Range:
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.52 | 367.73M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
Stop Loss: Can SOPHiA GENETICS SA continue delivering strong returnsWeekly Trade Recap & Verified Swing Trading Watchlist - baoquankhu1.vn
Big Money Moves: Is SOPHiA GENETICS SA exposed to political riskWeekly Trade Review & Proven Capital Preservation Tips - baoquankhu1.vn
Why analysts recommend SOPHiA GENETICS SA (90B) stockMarket Performance Summary & Free Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Sentiment Review: Why is SOPHiA GENETICS SA stock going downJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Levels: Is SOPHiA GENETICS SA stock a hidden gemJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Inside the platform analyzing 1.8M genomes to speed cancer insights - Stock Titan
Executive hires to help startups scale - Startupticker.
Aug Final Week: Is SOPHiA GENETICS SA a potential multi baggerQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
SOPHiA GENETICS Announces CEO Transition and Strong Preliminary 2025 Results - TipRanks
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - marketscreener.com
AI-driven medicine firm hands CEO job to insider after big 2025 - Stock Titan
SOPHiA GENETICS Reports Strong Q3 Growth and Raises Guidance - MSN
Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда
Will SOPHiA GENETICS SA stock maintain dividend yieldMarket Sentiment Review & Daily Risk Controlled Trade Plans - ulpravda.ru
Why SOPHiA GENETICS SA stock remains on buy listsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - Улправда
Published on: 2026-01-09 00:00:10 - ulpravda.ru
Will SOPHiA GENETICS SA (90B) stock outperform global peersJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru
Is SOPHiA GENETICS SA stock ready for breakoutQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Улправда
Income Plays: Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleWeekly Investment Recap & High Return Stock Watch Alerts - Улправда
Aug Sectors: Is SOPHiA GENETICS SA stock ready for breakoutWeekly Trade Analysis & Long Hold Capital Preservation Tips - Bộ Nội Vụ
How SOPHiA GENETICS SA stock benefits from global expansionStock Rotation Strategies & Access Free Risk Analysis Before You Invest - ulpravda.ru
Tech Rally: Will SOPHiA GENETICS SA 90B stock outperform global peers2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Sophia Genetics stock rises on MD Anderson Cancer Center partnership - Investing.com
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - Finviz
MD Anderson, SOPHiA GENETICS Join for AI Oncology Boost - Mirage News
SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care - Investing.com UK
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and Clover Health Investments (NASDAQ:CLOV) - Defense World
Will SOPHiA GENETICS SA stock benefit from upcoming earnings reports2026 world cup usa national team semifinals star players low block defense group prediction expert opinion - ulpravda.ru
Can Nirlon Limited (500307) Maintain Its ValuationMarket Capitalization Trends & Our Picks = Your Future Gains - bollywoodhelpline.com
RSI Reset May Fuel Rebound in Sanstar LimitedMerger & Acquisition Updates & Outperform With Our Smart Trading Calculator - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - Defense World
SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus - Kalkine Media
Reviving an old journey post retirementTrading Volume Surges & Build a Dividend-Powered Portfolio - bollywoodhelpline.com
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% HigherWhat's Next? - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher – What’s Next? - Defense World
Mukta Agriculture Limited Hits Oversold Level on RSI IndicatorHealthcare Stock Analysis & Real-Life Case Studies You Can Follow - bollywoodhelpline.com
Aug Chart Watch: Is SOPHiA GENETICS SA stock a buy before product launchesRisk Management & Stepwise Swing Trade Plans - moha.gov.vn
Swiss stocksFactors to watch on December 23 - marketscreener.com
A activityMarket Sentiment Report & Trade Opportunity Analysis Reports - Улправда
What is the fair value of SOPHiA GENETICS SA stock nowQuarterly Risk Review & Real-Time Volume Analysis Alerts - Улправда
Why SOPHiA GENETICS SA (90B) stock remains stableRecession Risk & Reliable Breakout Stock Forecasts - Улправда
What makes SOPHiA GENETICS SA stock attractive to growth fundsJuly 2025 Breakouts & Low Drawdown Investment Strategies - Улправда
VP Menu Files To Sell 608 Of SOPHiA GENETICS SA [SOPH] - TradingView — Track All Markets
Will SOPHiA GENETICS SA stock gain from government policies2025 Key Lessons & Real-Time Buy Signal Notifications - Улправда
Will SOPHiA GENETICS SA (90B) stock profit from fiscal stimulusPortfolio Performance Report & Safe Swing Trade Setup Alerts - DonanımHaber
Will SOPHiA GENETICS SA stock maintain momentum in 2025Weekly Trend Summary & Long-Term Capital Growth Strategies - Улправда
Can SOPHiA GENETICS SA stock maintain growth trajectoryPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Can SOPHiA GENETICS SA (90B) stock beat analyst consensus2025 Stock Rankings & Verified Momentum Stock Ideas - DonanımHaber
Is SOPHiA GENETICS SA stock a buy before product launches2025 Earnings Impact & Growth Oriented Trading Recommendations - DonanımHaber
Can SOPHiA GENETICS SA stock beat market expectations this quarterGold Moves & Weekly Breakout Watchlists - Улправда
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):